HOMA-IR — insulin resistance calculator
Calculate HOMA-IR from fasting glucose and fasting insulin. Four bands (high sensitivity / normal / borderline / resistant) with empathic.
What HOMA-IR estimates
The Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) is a calculation derived from a single fasting blood sample that estimates how much insulin your body needs to keep blood glucose stable. Matthews and colleagues introduced it in 1985 (Diabetologia 1985;28:412–419) as a research tool; it is now widely used in metabolic medicine, endocrinology, and PCOS / NAFLD work-ups as a low-cost screening proxy for insulin resistance.
HOMA-IR is screening, not diagnostic. ADA does not endorse it as a primary clinical decision tool, partly because cut-offs vary by population and partly because more direct tests (HbA1c, OGTT) exist for prediabetes and diabetes. Where HOMA-IR is most useful: tracking metabolic trend before glucose becomes elevated, providing context in PCOS or fatty liver evaluations, and screening high-risk family members.
The formula
HOMA-IR = (fasting glucose × fasting insulin) / 22.5 (glucose in mmol/L, insulin in μIU/mL)
HOMA-IR = (fasting glucose × fasting insulin) / 405 (glucose in mg/dL, insulin in μIU/mL)
Both forms give the same number. The calculator accepts either unit and converts automatically.
Bands (Polish / European-leaning thresholds)
| HOMA-IR | Band |
|---|---|
| < 1.0 | High insulin sensitivity |
| 1.0 – 2.0 | Normal |
| 2.0 – 2.5 | Borderline / increased risk |
| ≥ 2.5 | Insulin resistance |
Polish endocrinology and many European labs use 2.5 as the resistance threshold; some US labs use 2.6–3.0. Asian populations tend to have lower thresholds (often 1.8–2.0). The trend over time is more reliable than any single number.
How to interpret a result
- Single sample variability is 15–25 % between draws. Confirm with a repeat sample 2–4 weeks apart if you can.
- Acute illness, intense exercise the day before, alcohol, or significant stress can all shift HOMA-IR transiently. Try to test under typical conditions.
- Insulin must be measured in the same blood draw as glucose for the calculation to be valid. A mismatched sample is uninterpretable.
- HOMA-IR is only meaningful in the early-to-mid stages of metabolic dysfunction. In advanced type 2 diabetes the pancreas can no longer produce enough insulin, so HOMA-IR underestimates the true resistance.
What raises HOMA-IR
- Excess body fat, especially abdominal (visceral) fat
- Sedentary lifestyle, prolonged sitting
- Sleep deprivation or poor sleep quality
- Chronic stress, elevated cortisol
- Polycystic ovary syndrome (PCOS)
- Non-alcoholic fatty liver disease (NAFLD)
- Family history of type 2 diabetes
- Some medications (corticosteroids, certain antipsychotics, some HIV medications)
What lowers HOMA-IR
- 150–300 minutes per week of moderate aerobic exercise
- 2–3 strength training sessions per week
- 5–7% weight loss if overweight (often reduces HOMA-IR by 30–50%)
- 7–9 hours of regular sleep
- Diet patterns emphasising fibre (vegetables, legumes, whole grains) and protein over refined carbohydrates
- Time-restricted eating in some studies (modest effect)
Why early action matters
Insulin resistance often precedes type 2 diabetes by 5–10 years. The Diabetes Prevention Program (Knowler 2002) showed that structured lifestyle change reduces incident type 2 diabetes by 58% over 3 years in adults with prediabetes. Reversal is most achievable in the borderline and early resistance bands; once beta-cell function declines, restoring full insulin sensitivity becomes harder.
Pair with our other tools
- Glucose unit converter & ADA interpretation — fasting glucose, OGTT, HbA1c interpretation.
- BMI calculator — weight category screening.
Privacy
All calculations run in your browser. We never see, log, or store your glucose or insulin values. Only an anonymous event (locale, band) is sent to a privacy-respecting analytics service.
Licence
The HOMA-IR formula is in the public domain. The original publication: Matthews D. R. et al., “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia 1985;28:412–419.
Frequently asked questions
What does HOMA-IR measure?
How is HOMA-IR calculated?
What is a normal HOMA-IR?
Is HOMA-IR a diagnosis?
When is HOMA-IR not reliable?
What if my HOMA-IR is high?
Does my data leave the device?
More health calculators
Calculators →- BMR & TDEE Calculator Calculate your basal metabolic rate (BMR) and total daily energy expenditure (TDEE) using the Mifflin-St Jeor equation — the formula clinicians.
- BMI Calculator Free BMI calculator with WHO classification. Switch between kg/cm and lb/in. Sources cited (WHO, CDC, NHS), calculation runs in your browser.
- Body Fat Percentage Calculator Free body fat percentage calculator using the US Navy circumference method (Hodgdon 1984). Tape measure only. ACE 2018 reference categories.
- FINDRISC diabetes risk calculator FINDRISC 8-question type 2 diabetes risk score. Validated by Lindström and Tuomilehto (2003). Estimates 10-year risk without a blood test.
- Glucose unit converter and interpretation Convert glucose units and HbA1c (% ↔ mmol/mol). Get fasting / OGTT / random / HbA1c interpretation under ADA 2024 — normal, prediabetes, diabetes ranges.
- Macro Calculator Free macro calculator using Mifflin-St Jeor BMR + ISSN protein guidelines. Cut, maintain, or bulk — we split TDEE into grams of protein, carbs, and.
Sources
- Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man — Diabetologia (Matthews et al., 1985) — original derivation (peer reviewed, retrieved 2026-04-30)
- Standards of Care in Diabetes — 2024 — American Diabetes Association (ADA, 2024) (guideline, retrieved 2026-04-30)
- Reduction in the Incidence of Type 2 Diabetes With Lifestyle Intervention or Metformin (DPP) — N Engl J Med (Knowler et al., 2002) (peer reviewed, retrieved 2026-04-30)
- Use and abuse of HOMA modeling — Diabetes Care (Wallace, Levy, Matthews, 2004) (peer reviewed, retrieved 2026-04-30)